Charles River works on rare disease gene therapy; Emergent gets $75M for anthrax vaccine; EuroAPI hires new COO 

Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.

Charles River and the Australian nonprofit Genetic Cures for Kids partnered on Tuesday to develop and manufacture a gene therapy for the hereditary neurodegenerative disease called…
Click here to view original post